Literature DB >> 18201268

Changing patterns in the frequency of Hodgkin lymphoma subtypes and Epstein-Barr virus association in Taiwan.

Kung-Chao Chang1, Paul Chih-Hsueh Chen, Dan Jones, Ih-Jen Su.   

Abstract

Epstein-Barr virus (EBV) infection is a risk factor for Hodgkin lymphoma (HL). To test whether the frequency of HL subtypes and their association with EBV has shifted with rising socioeconomic status in Taiwan, we compared the pathological features and EBV status, detected by in situ hybridization, of HL diagnosed between 1996 and 2007 (99 cases) and 1982 and 1995 (74 cases). The male-to-female ratio was 121:52 (2.3:1) and the mean age at presentation was 41.5 years. The overall EBV positivity rate was 50% (86/173 cases). Comparing the distribution of HL cases diagnosed at two different time periods, we found an increased frequency of the nodular sclerosis (NS) subtype (53 vs 68%, P = 0.045), a decreased frequency of the mixed cellularity subtype (35 vs 13%, P < 0.001), a reduced male-to-female ratio (2.9:1 compared to 1.4:1) and mean age (42.4 vs 36.6 years) in the NS subtype, and a significant decrease in EBV positivity rates among the NS and lymphocyte-depletion subtypes (61 vs 39%, P = 0.03). These data indicate shifts in the frequency of histological subtype and EBV association for HL in Taiwan over the last decade, with a trend closer to that seen in Western countries and Japan.

Entities:  

Mesh:

Year:  2008        PMID: 18201268     DOI: 10.1111/j.1349-7006.2007.00667.x

Source DB:  PubMed          Journal:  Cancer Sci        ISSN: 1347-9032            Impact factor:   6.716


  9 in total

Review 1.  Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments.

Authors:  Lingyun Geng; Xin Wang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

2.  Epstein-Barr virus and Hodgkin's lymphoma in Cairo, Egypt.

Authors:  Josée Audouin; Jacques Diebold; Bharat Nathwani; Elia Ishak; Kenneth Maclennan; Hans Konrad Mueller-Hermelink; James O Armitage; Dennis D Weisenburger
Journal:  J Hematop       Date:  2010-05-28       Impact factor: 0.196

Review 3.  Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.

Authors:  Jorge J Castillo; Brady E Beltran; Roberto N Miranda; Semra Paydas; Eric S Winer; James N Butera
Journal:  Oncologist       Date:  2011-01-06

4.  New developments in the pathology of malignant lymphoma: a review of the literature published from January to April 2008.

Authors:  J Han J M van Krieken
Journal:  J Hematop       Date:  2008-07       Impact factor: 0.196

5.  Changing patterns in the clinical pathological features of hodgkin lymphoma: a report from debrecen, hungary.

Authors:  Zsófia Miltényi; Zsófia Simon; Edit Páyer; László Váróczy; Lajos Gergely; Adám Jóna; Arpád Illés
Journal:  ISRN Hematol       Date:  2011-12-01

6.  Epstein-Barr virus latent membrane protein-1 upregulates autophagy and promotes viability in Hodgkin lymphoma: Implications for targeted therapy.

Authors:  Hui-Chen Lin; Yao Chang; Ruo-Yu Chen; Liang-Yi Hung; Paul Chih-Hsueh Chen; Ya-Ping Chen; L Jeffrey Medeiros; Po-Min Chiang; Kung-Chao Chang
Journal:  Cancer Sci       Date:  2021-02-16       Impact factor: 6.716

7.  Aberrant expression of ID2 protein and its correlation with EBV-LMP1 and P16(INK4A) in classical Hodgkin lymphoma in China.

Authors:  Po Zhao; Yali Lu; Lin Liu; Mei Zhong
Journal:  BMC Cancer       Date:  2008-12-19       Impact factor: 4.430

8.  Time Trends in Rates of Hodgkin Lymphoma Histologic Subtypes: True Incidence Changes or Evolving Diagnostic Practice?

Authors:  Sally L Glaser; Christina A Clarke; Theresa H M Keegan; Ellen T Chang; Dennis D Weisenburger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-07-27       Impact factor: 4.090

9.  Malignant lymphomas (ML) and HIV infection in Tanzania.

Authors:  Amos R Mwakigonja; Ephata E Kaaya; Edward M Mgaya
Journal:  J Exp Clin Cancer Res       Date:  2008-06-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.